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Abstract: 
In heart failure (HF) patients frailty syndrome and cognitive impairment (CI) affect outcome by 
decreasing the capability for performing self-care, adhering to the prescribed treatment regimen, 
monitoring symptoms. 
The aim was to investigate whether CI affects the compliance to therapeutic regimens. 
Methods: 170 with HF were included. We employed the Mini Mental State Examination (MMSE), for 
dementia and the Revised Heart Failure Compliance Scale to assess compliance. 
Results: CI patients showed lower compliance in all domains: 2.8±1.0 vs 3.3±1.0 (keeping 
appointments), 2.8±0.9 vs. 3.4±0.9 (pharmaceutical compliance), 0.4±0.8 vs. 1.4±1.2 (regular body 
weight monitoring), 2.0±1.3 vs. 2.7±1.0 (reduced salt intake), 1.9±1.2vs. 2.9±1.0 (fluid intake 
restriction), and 0.5±0.8 vs. 1.7±1.1 (regular exercise). Multiple regression analysis showed cognitive 
function to be an independent predictor for regular body weight monitoring (β=1.223;p<0.001), fluid 
intake restriction (β=1.081;p<0.001), and regular exercise (β=1.237;p<0.001). In multivariate analysis, 
the stimulant variables for compliance with HF treatment were: education (β=1.124), being in a 
relationship (β=2.231), and lack of cognitive impairment (β=0.320); the number of hospitalizations 
due to HF was identified as a destimulant (β=-0.495). 
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Conclusion: Non-compliance is a major problem in elderly with HF. The cognitive function is an 
independent contributor to total compliance and to compliance with non-pharmaceutical 
recommendations. Being in a relationship and education are independent predictors of better 
compliance, while the number of rehospitalizations due to HF exacerbations is an independent 
predictor of worse compliance. Early detection of CI may offer an opportunity for intervention and a 
key strategy for improving clinical outcomes in older adults with HF. 
 
 
 
Streszczenie: 
U pacjentów z niewydolnością serca występowanie zespołu kruchości i zaburzeń funkcji 
poznawczych może wpływać na efekty leczenia, poprzez zmniejszenie możliwości 
samoopieki, przestrzegania ustalonych schematów terapeutycznych oraz upośledzenie 
monitorowania objawów. 
Celem badania była ocena związku funkcji poznawczych z przestrzeganiem zaleceń terapeutycznych 
w leczeniu niewydolności serca.  
Metody: Do badania włączono 170 pacjentów z rozpoznaną niewydolnością serca. W badaniu 
wykorzystano Mini Mental State Examination (MMSE) do oceny funkcji poznawczych oraz  
Revised Heart Failure Compliance Scale (RHFCS) do oceny przestrzegania zaleceń terapeutycznych 
ograniczania podaży sodu w diecie, ograniczenia płynów, codziennego ważenia i aktywności 
fizycznej. 
Wyniki 
Pacjenci z zaburzeniami funkcji poznawczych mają niższy poziom przestrzegania zaleceń w zakresie 
wszystkich domen kwestionariusza RHFCS, stosownie: przestrzeganie wizyt kontrolnych (2.8 ± 1.0 vs 
3.3 ± 1.0), przestrzeganie zaleceń farmakologicznych (2.8 ± 0.9 vs. 3.4 ± 0.9), regularna kontrola 
masy ciała (0.4 ± 0.8 vs. 1.4 ± 1.2), ograniczenia spożycia soli (2.0 ± 1.3 vs. 2.7 ± 1.0), ograniczenia 
spożycia płynów (1.9 ±1.2 vs. 2.9 ±1.0), regularna aktywność fizyczna (0.5 ±0.8 vs. 1.7 ±1.1). Analiza 
regresji wielorakiej pokazała, że funkcje poznawcze są niezależnym predyktorem związanym z 
regularną kontrolą masy ciała (β=1.223; p<0.001), ograniczeniem płynów (β=1.081; p<0.001) i 
regularną aktywnością fizyczną (β=1.237; p<0.001). W analizie wieloczynnikowej niezależnymi 
predyktorami dostosowania do terapii niewydolności serca (stymulantami) okazały się: wykształcenie 
(β-1.124), życie w związku (β=2.231) i brak zaburzeń funkcji poznawczych (suma punktów 
kwestionariusza MMSE) (β=0.320) natomiast destymulantem - liczba hospitalizacji z powodu 
niewydolności serca. (β=-0.495) 
Wnioski 
1. Nieprzestrzeganie zaleceń terapeutycznych jest istotnym problemem wśród pacjentów z 
niewydolnością serca w wieku podeszłym.  
2. Funkcje poznawcze są niezależnym predyktorem mającym związek z przestrzeganiem zaleceń 
terapeutycznych. 
3. Życie w związku i wykształcenie są niezależnymi predyktorami zwiększającymi przestrzeganie 
zaleceń terapeutycznych, natomiast liczba rehospitalizacji z powodu zaostrzenia niewydolności serca 
jest niezależnym predyktorem obniżającym przestrzeganie zaleceń terapeutycznych.  
4. Wczesne rozpoznawanie zaburzeń funkcji poznawczych może przyczyniać się do lepszego 
planowania interwencji i strategii zmierzającej do poprawy przestrzegania zaleceń i zwiększenia 
skuteczności leczenia.  
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Introduction 
Heart failure (HF) is a major epidemiological and clinical issue. The number of HF patients amounts 
to over 23 million cases worldwide i.e. the disease affects approximately 2–3% of the total population 
[1] and 10–20% of the elderly population (7.8% of men and 4.5% of women above 60, and 8.6% of 
men and 11.5% of women above 80 [2]). 
Because over 80% of HF patients are aged 65 or over, they tend to suffer from a range of other 
concurrent diseases and clinical syndromes. Frequent comorbidities include frailty syndrome and 
cognitive impairment, which may significantly affect compliance with therapeutic regimens, and 
which are related to a higher number of hospitalizations and higher mortality in elderly HF patients 
[3,4]. 
Despite the high prevalence of frailty and cognitive impairment in the HF patients‘ population, these 
conditions are not routinely screened for in clinical settings and guidelines on optimal assessment 
strategies are lacking [5]. 
Most available studies estimate the prevalence of cognitive impairment in HF patients at 25% 
[6], but much higher rates have also been reported [7–12]. In a study by Cameron et al. on patients 
hospitalized for HF, moderate cognitive impairment was found in as many as 73% of participants [13]. 
Unfortunately, most studies of cognitive deficits in HF include small patient groups and use diverse 
definitions of cognitive impairment. Harkness et al. [14] stated that patients who had recently been 
hospitalized are likely to suffer from more severe cognitive impairment, while other studies have 
included similar reports about patients with severe left ventricular dysfunction [15].  
Numerous studies indicate that patients with HF are at a higher risk of cognitive impairment than those 
without HF [8,10,11] or with other cardiovascular diseases [8]. 
Despite available treatment options, prognosis is poor. One in five patients is rehospitalized 
within the first month after discharge, and one in three within the next two months. 80% of HF 
hospitalizations are rehospitalizations due to exacerbation [16]. Statistics on 1-year and 5-year 
mortality from HF present similar findings [17]. One significant cause of rehospitalization is non-
adherence to treatment. Medication adherence is one of a constellation of self-care behaviors (i.e. 
adherence to treatment regimens, symptom monitoring and symptom management) that can improve 
HF outcomes.  
The World Health Organization defines compliance as ―the extent to which the behavior 
corresponds with agreed recommendations from a health care provider‖ [11]. 
Among HF patients, the rates of adherence reported in studies vary between 10 and 98%, depending 
on the measurement instruments used [18-20].  
Apart from pharmaceutical treatment, lifestyle changes are a significant part of HF patient care and 
management. Nieuwenhuis et al. [21] demonstrated in their study that 72% of HF patients comply 
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with four out of six therapeutic recommendations, including pharmaceutical treatment (98%), follow-
up visits (95%), restrictions in salt (79%) and fluid intake (73%), and daily weighing (35%) [21]. Poor 
pharmaceutical compliance and lack of lifestyle changes are problems found in one in three HF 
patients.  
According to patients, one of the most common causes of non-adherence is difficulty in 
complying with the physician‘s orders due to incomprehension. Patients also report difficulty 
obtaining prescription renewals, treatment side effects, financial barriers, and memory deficits [22]. 
The WHO also states that disability and cognitive impairment are more common in elderly patients 
and constitute the most frequent cause of non-adherence. Cognitive impairment may affect outcomes 
by impeding self-care in heart failure, adherence to medication, symptom monitoring, dietary 
compliance, and daily weighing. Cognitive impairment may interfere with any of these necessary 
tasks; for example, doses of diuretics may be missed, or changes in symptoms (dyspnea, weight gain) 
may not be recognized until they become severe.  
However, few papers have as yet assessed the correlation between cognitive impairment and 
adherence to treatment in elderly heart failure patients.  
Material and methods 
The aim of this study was to investigate whether cognitive impairment affects the level of adherence to 
therapeutic regimens and treatment in HF patients. The study involved patients suffering from HF and 
treated with oral medication and lifestyle changes. The following questions were posed in this study: 
1. Does adherence differ between patients with and without cognitive impairment?  
2. Is there any correlation between social (sex, age, marital status, education) and clinical 
variables (cognitive impairment, NYHA class, duration of illness, prescribed pharmaceutical 
treatment, left ventricular ejection fraction, number of rehospitalizations), and adherence to 
pharmaceutical and non-pharmaceutical treatment in HF? 
Study design and sample 
The study was conducted between January and August 2016, as a cohort study on a consecutive 
sample of 195 adults with a confirmed diagnosis of HF, enrolled from outpatient sites in the Lower 
Silesian Specialist Hospital. The study included patients scheduled for follow-up visits within the 
study period. The patients were recruited by a cardiologist on the basis of the relevant inclusion and 
exclusion criteria. Inclusion criteria were as follows: (1) age > 65 years, (2) clinically confirmed heart 
failure diagnosis, (3) the patient's written informed consent. Exclusion criteria were as follows: (1) 
age< 65, (2) requirement for intensive cardiac care, (3) history of stroke in the last six months, (4) 
inability to complete the questionnaires or lack of consent to participate in the study, (5) severe 
depression or terminal illness. 
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Ultimately, 25 patients were excluded. The study included 170 patients over 65 years of age, 
diagnosed with HF, receiving optimal treatment for at least six months. Questionnaires were 
distributed by a cardiac nurse. All patients were informed of the purpose and nature of our study, and 
provided written informed consent to participate. All patients completed all questionnaires. 
Demographic and socio-demographic data (age, sex, years of education, marital status) were obtained 
from interviews performed by a cardiac nurse and from patient records. Clinical data, such as the New 
York Heart Association (NYHA) functional class, left ventricular ejection fraction (EF), number of 
rehospitalizations, and the medication taken were obtained from records and from personal interviews 
with the participants performed by a cardiac nurse. 
Instruments 
We used the Mini Mental State Examination (MMSE), developed by M. Folstein et al. It is a 
widely used screening test for dementia, whose advantages include speed of administration and 
simplicity of result interpretation [25]. The MMSE measures cognitive functions such as sense of 
direction, memory, attention, linguistic function, and visual–spatial abilities, as well as the ability to 
count, recall things, repeat, and carry out orders [25]. The possible score ranges from 0 to 30, with 
lower scores indicating more severe cognitive disorders. Patients with scores ≤23 are described as 
cognitively impaired [25]. 
Compliance with recommendations regarding a sodium-restricted diet, fluid restriction, exercise, and 
daily weighing was measured using the Revised Heart Failure Compliance Scale. Compliance was 
measured on a 5-point scale (0 = never; 1 = seldom; 2 = half of the time; 3 = mostly; 4 = always). 
Patients were asked to rate their compliance in the past week (medication, sodium-restricted diet, fluid 
restriction, and exercise), the past month (daily weighing), or the last 3 months (appointment keeping) 
before index hospitalization. Patients were defined as compliant when they followed a 
recommendation ‗always‘ or ‗mostly‘. Regarding daily weighing, patients were considered compliant 
when they weighed themselves daily or ≥3 times a week. Patients were considered to be ―overall 
compliant‖ when they complied with ≥4 out of the 6 recommendations. The questionnaire has good 
psychometric properties — Cronbach‘s alpha: 0.768, average inter-item correlation: 0.362.  
The study was approved by the Bioethics Committee of the Wrocław Medical University, approval no. 
KB 67/2016.  
Statistical analysis 
1. The normality of the empirical distribution of quantitative variables was verified using the 
Shapiro–Wilk test. Mean values and standard deviations for the quantitative variables were 
calculated. The mean values were compared in three groups of patients using one-way 
analysis of variance (ANOVA). If the null hypothesis on the lack of differences between 
the groups was rejected, post hoc tests were performed (multiple comparison tests and the 
least significant difference (LSD) test).  
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2. Qualitative and ordinal variables were grouped into contingency tables, the values of these 
variables were summed (ni), and percentages were calculated. The independence of the 
qualitative variables was verified using Pearson‘s chi squared test. The strength of 
correlations among variables was determined by calculating the Spearman‘s rank 
correlation coefficient (rho) and its significance (p). Findings were considered statistically 
significant at p < 0.05. 
3. Multivariate linear regression analysis was used to assess the influence of independent 
variables on adherence. The forward stepwise approach was used to select variables. First, 
assumptions regarding the application of the least square method were verified, and 
analysis was performed to check for the presence of outliers. The standardized coefficients 
β and regression coefficients b were calculated for explanatory variables (MMSE and age). 
The statistical significance of particular variables in the model was verified using Student‘s 
t-test. The quality of the proposed linear multivariate regression model was evaluated by 
means of standard error of estimation (SEe). 
4. The statistical analysis was performed using the Statistica v. 10 software.  
 
Results: 
The survey included 170 patients with heart failure (90 female), aged 65 to 93 (mean M = 
71.9±7.7 years). Participant characteristics were analyzed based on the patients‘ cognitive function 
scores. The basic socio-demographic characteristics of patients, broken down by cognitive function 
scores, are shown in the table. Patients in the cognitively impaired group were mostly female (69.7 % 
vs 42.3%), older (74 vs 68 y/o), single (71.2% vs 36.5%), and less educated (63.6% with primary 
education) (table 1). 
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Table 1. Socio-demographic characteristics of HF patients by cognitive function 
Tabela 1. Charakterystyka socjo-demograficzna pacjentów z niewydolnością serca w zależności od 
wyniku kwestionariusza MMSE i zaburzeń funkcji poznawczych.  
Characteristic 
Total 
Cognitive function 
p test 
result 
 
normal MMSE 
score (>23) 
MMSE score 
indicating 
impairment (≤23) 
 
N = 170 N = 104 N = 66 
Age (years):    
<0.001 Me (Q1; Q2) 70 (65; 77) 68 (65; 73) 74 (69; 82) 
Min – Max 61 – 93 61 – 93 63 – 87 
Sex: n % n % n % 
<0.001 Male 80 47.1% 60 57.7% 20 30.3% 
Female 90 52.9% 44 42.3% 46 69.7% 
Residence: n % n % n % 
0.609 Urban 136 80.0% 85 81.7% 51 77.3% 
Rural 34 20.0% 19 18.3% 15 22.7% 
Education:       
<0.001 
Primary 73 42.9% 31 29.8% 42 63.6% 
High school 57 33.5% 40 38.5% 17 25.8% 
College/University 40 23.5% 33 31.7% 7 10.6% 
Relationship status:       
<0.001 Single 85 50.0% 38 36.5% 47 71.2% 
In a relationship 85 50.0% 66 63.5% 19 28.8% 
MMSE-Mini Mental State examination, Me-median,  
 
The patients studied also had different clinical characteristics. Cognitively impaired patients 
had had HF longer (mean duration of illness 6.0 vs 5.6 years), were diagnosed with NYHA class IV 
more often (33.3% vs 15.3%) and had had more hospitalizations due to HF exacerbations in the 
previous six months (Me = 3 vs 2) than those with normal cognitive function (table 2). 
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Table 2. Clinical characteristics of HF patients by cognitive function 
Tabela 2. Charakterystyka kliniczna pacjentów z niewydolnością serca w zależności od wyniku kwestionariusza 
MMSE i zaburzeń funkcji poznawczych. 
Characteristic 
Total 
Cognitive function 
p test 
result 
 
normal MMSE 
score (>23) 
MMSE score 
indicating 
impairment (≤23) 
N = 170 
Duration of illness in years    
0.013 Me (Q1; Q2) 5.8 (3; 7) 5.6 (3; 6) 6.0 (4; 7) 
Min – Max 1 – 31 1 – 31 1 – 15 
Comorbidities: n % n % n %  
Ischemic heart disease 88 51.8% 55 52.9% 33 50.0% 0.834 
Arterial hypertension 37 21.8% 23 22.1% 14 21.2% 0.959 
Valvular heart disease 28 16.5% 21 20.2% 7 10.6% 0.153 
Cardiomyopathy 29 17.1% 18 17.3% 11 16.7% 0.920 
Diabetes mellitus 39 22.9% 21 20.2% 18 27.3% 0.377 
NYHA class       
<0.001 
II 93 54.7% 72 69.3% 21 31.8% 
III 51 30.0% 28 26.9% 23 34.8% 
IV 26 15.3% 4 3.8% 22 33.3% 
Medication used:        
ACE inhibitors 135 79.4% 86 82.7% 49 74.2% 0.257 
Diuretics 150 88.2% 88 84.6% 62 93.9% 0.087 
Glycosides 23 13.5% 18 17.3% 5 7.6% 0.115 
Beta-blockers 80 47.1% 43 41.3% 37 56.1% 0.086 
CCBs 2 1.2% 1 1.0% 1 1.5% 1.000 
Ejection fraction (EF %)    
0.208 Me (Q1; Q2) 40 (35; 50) 45 (35; 55) 40 (35; 50) 
Min – Max 20 – 70 20 – 70 20 – 60 
Number of 
hospitalizations    
<0.001 
Me (Q1; Q2) 2.5 (1; 4) 2 (1; 3) 3 (2; 4) 
Min – Max 0 – 8 0 – 8 0 – 7 
NYHA-  New York Heart Association, Me-median, CCB Calcium channel blockers, ACE angiotensin-
converting-enzyme inhibitor, EF- Ejection fraction 
 
Scoring of compliance with heart failure treatment using the Revised Heart Failure 
Compliance Scale in groups of patients identified based on their cognitive function demonstrated that 
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cognitively impaired patients (MMSE≤23) showed lower compliance in all domains of the 
questionnaire, i.e.: 2.8 ± 1.0vs 3.3 ± 1.0 for keeping follow-up appointments, 2.8 ± 0.9 vs. 3.4 ± 0.9 for 
pharmaceutical compliance, 0.4 ± 0.8 vs. 1.4 ± 1.2 for regular body weight monitoring, 2.0 ± 1.3 vs. 
2.7 ± 1.0 for reduced salt intake, 1.9 ±1.2 vs. 2.9 ± 1.0 for fluid intake restriction, and 0.5 ± 0.8 vs. 1.7 
± 1.1 for regular exercise. With the total compliance scores calculated, a statistically significant 
difference was found between the two groups. The cognitively impaired group obtained a total 
compliance score of 10.4 ± 4.0 points, while patients with normal cognitive function obtained 15.3 ± 
3.6 points (table 3). 
 
Table 3. Compliance with heart failure treatment as scored using the Revised Heart Failure 
Compliance Scale in groups of patients identified based on cognitive function — comparison results 
Tabela 3. Analiza porównawcza przestrzegania zaleceń terapeutycznych kwestionariuszem 
Revised Heart Failure Compliance Scale w zależności od wyniku kwestionariusza MMSE i zaburzeń 
funkcji poznawczych. 
Adherence to heart failure treatment  
(RHFCS questionnaire) 
Total 
Cognitive function  
normal 
MMSE score 
(>23) 
MMSE score 
indicating 
impairment 
(≤23) 
p test 
result 
 N = 170  
1. Follow-up appointment keeping    
<0.001 
M  SD 3.1 ± 1.0 3.3 ± 1.0 2.8 ± 1.0 
Me (Q1; Q3) 3 (2; 4) 4 (3; 4) 3 (2; 4) 
Min – Max 0 – 4 0 – 4 1 – 4 
2. Taking medication as prescribed    
<0.001 
M  SD 3.1 ± 0.9 3.4 ± 0.9 2.8 ± 0.9 
Me (Q1; Q3) 3 (2; 4) 4 (3; 4) 2 (2; 4) 
Min – Max 0 – 4 0 – 4 2 – 4 
3. Daily weighing     
<0.001 
M  SD 1.0 ± 1.1 1.4 ± 1.2 0.4 ± 0.8 
Me (Q1; Q3) 1 (0; 2) 2 (0; 2) 0 (0; 1) 
Min – Max 0 – 3 0 – 3 0 – 3 
4. Reduced sodium intake    
0.003 
M  SD 2.4 ± 1.2 2.7 ± 1.0 2.0 ± 1.3 
Me (Q1; Q3) 3 (2; 3) 3 (2; 3) 2 (1; 3) 
Min – Max 0 – 4 0 – 4 0 – 4 
5. Restricted fluid intake     
<0.001 
M  SD 2.5 ± 1.2 2.9 ± 1.0 1.9 ± 1.2 
Me (Q1; Q3) 3 (2; 3) 3 (2; 4) 2 (1; 3) 
Min – Max 0 – 4 0 – 4 0 – 4 
6. Regular exercise     
<0.001 
M  SD 1.2 ± 1.2 1.7 ± 1.1 0.5 ± 0.8 
Me (Q1; Q3) 1 (0; 2) 2 (1; 3) 0 (0; 1) 
Min – Max 0 – 4 0 – 4 0 – 3 
Total compliance score (points)    
<0.001 
M  SD 13.4 ± 4.5 15.3 ± 3.6 10.4 ± 4.0 
Me (Q1; Q3) 14 (10; 17) 16 (13; 18) 11 (7; 14) 
Min – Max 4 – 23 7 – 23 4 – 18 
RHFCS- Revised Heart Failure Compliance Scale, Me-median, SD- standard deviation, M-average 
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A very strong correlation was found between the total score in the MMSE cognitive function 
questionnaire and the total score in the RHFCS compliance questionnaire (r = 0.753). (fig. 1). 
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Fig. 1. Correlation diagram for cognitive function (MMSE score) and compliance with treatment 
(RHFCS score) in patients with HF 
Fig. 1. Diagram korelacyjny pomiędzy zaburzeniami funkcji poznawczych (MMSE) a stosowaniem 
się do zaleceń lekarskich (RHFCS) pacjentów z niewydolnością serca 
 
Analysis of correlations between cognitive function scores and compliance with treatment — 
Spearman‘s rho 
Correlation analysis (Spearman‘s rho) and simple regression (b) results for total MMSE score 
and the RHFCS compliance domains show a statistically significant correlation between cognitive 
function and compliance with treatment in all domains studied: follow-up appointment keeping 
(rho=0.212; p=0.006), medication taking (rho=0.331; p<0.001), body weight monitoring (rho=0.516; 
p<0.001), salt restriction (rho=0.253; p=0.001), fluid intake restriction (rho=0.431; p<0.001), and 
regular exercise (rho=0.533; p=<0.001), as well as total compliance scores (rho=0.555; p<0.001). 
Simple regression analysis showed a similar association between MMSE scores and total RHFCS 
scores. The results are shown in table 4. 
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Table 4. Correlation analysis (Spearman‘s rho) and simple regression (b) results for total MMSE score 
and the RHFCS compliance domains 
Tabela 4.Wyniki analizy korelacji (rho Spearmana) i regresji prostej (b) pomiędzy sumą punktów 
kwestionariusza MMSE a domenami compliance kwestionariusza RHFCS oceniające dostosowanie 
się do zaleceń terapeutycznych. 
 
Compliance with HF treatment domains  
(RHFCS question number) 
Correlation 
analysis 
Regression 
analysis 
rho p b p 
Follow-up appointment keeping 0.212 0.006 0.041 0.010 
Taking medication as prescribed 0.331 <0.001 0.057 <0.001 
Daily weighing 0.516 <0.001 0.113 <0.001 
Reduced sodium intake  0.253 0.001 0.071 <0.001 
Restricted fluid intake 0.431 <0.001 0.110 <0.001 
Exercise  0.533 <0.001 0.127 <0.001 
Total compliance score 0.555 <0.001 0.519 <0.001 
RHFCS- Revised Heart Failure Compliance Scale, MMSE-Mini Mental State Examination, rho- Spearman‘s rho 
 
Multiple-factor analysis 
Subsequently, multiple-factor analysis was performed for associations between cognitive 
function and the RHFSC compliance domains. Multiple regression analysis showed cognitive function 
to be an independent predictor for regular body weight monitoring (β=1.223; p<0.001), fluid intake 
restriction (β=1.081; p<0.001), and regular exercise (β=1.237; p<0.001). The model was found to be 
statistically significant: F(3.166) = 39.1; p<0.001 (table 5). 
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Table 5. Pearson‘s linear regression coefficients (b) for cognitive impairment (MMSE) and RHFCS 
questions assessing compliance with treatment 
Tabela 5. Wartości współczynników regresji liniowej Pearsona (b) pomiędzy zaburzeniami funkcji 
poznawczych (MMSE) a domenami kwestionariusza RHFCS oceniającego stosowanie się do zaleceń 
lekarskich 
RHFCS questions 
Simple 
regression 
Multiple 
regression 
b p beta p 
Regular follow-ups in the past 3 months +0.940 0.010 0 NS 
Pharmaceutical compliance +1.584 <0.001 0 NS 
Daily weighing +2.129 <0.001 +1.223 <0.001 
Reduced sodium intake +1.153 <0.001 0 NS 
Restricted fluid intake +1.922 <0.001 +1.081 <0.001 
Regular exercise +2.179 <0.001 +1.237 <0.001 
Total compliance score +0.607 <0.001 0 NS 
RHFCS- Revised Heart Failure Compliance Scale, MMSE-Mini Mental State Examination 
 
Linear correlation analysis for compliance with treatment and selected predictors 
Linear correlation analysis included the socio-demographic and clinical variables that differed 
between the patient groups studied (tables 1 and 2). 
Univariate analysis showed that total compliance scores were positively affected by: education 
(b=2.449), being in a relationship (b=2.449) and MMSE scores (b=0.519); and negatively affected by: 
age (b=-0.126), NYHA class (b=-2.671) and the number of hospitalizations due to HF (b=-1.066). In 
multivariate analysis, the following predictors (stimulant variables) for compliance with heart failure 
treatment were identified: education (β=-1.124), being in a relationship (β=2.231) and lack of 
cognitive impairment as measured by the MMSE questionnaire (β=0.320); the number of 
hospitalizations due to HF was identified as a destimulant (β=-0.495) — table 6. The model was found 
to be adequate: F(4.165) = 36.2; p<0.001. 
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Table 6. Multivariate linear correlation coefficients for compliance with treatment (total RHFCS 
score) and the predictors analyzed 
Tabela 6. Wartości współczynnika korelacji liniowej pomiędzy stosowaniem się do zaleceń lekarskich 
(zsumowana ocena compliance wg kwestionariusza RHFCS) a analizowanymi predyktorami.  
Predictor 
Univariate analysis Multivariate analysis 
b p b p 
Age -0.126 0.004 0 NS 
Male 0.460 0.506 0 NS 
Education  2.449 <0.001 1.124 0.002 
Relationship status — in a 
relationship 
3.941 <0.001 2.231 <0.001 
Duration of illness 0.014 0.853 0 NS 
NYHA class -2.671 <0.001 0 NS 
Number of hospitalizations -1.066 <0.001 -0.495 0.002 
MMSE – total score 0.519 <0.001 0.320 <0.001 
RHFCS- Revised Heart Failure Compliance Scale, MMSE-Mini Mental State Examination, NYHA-  New York 
Heart Association 
 
RHFCS = 4.16 + 1.124  Education + 2.231  Not lonely – 0.495  No of hosp. + 0.320  MMSE 
 
Discussion: 
An improved understanding of the determinants associated with adherence to medication and 
health behaviors has become an important factor in management strategies for HF. The ability to 
identify indicators of low medication adherence is crucial for both improving clinical care and 
determining the targets of intervention for the prevention of complications in HF and for HF treatment. 
The purpose of the study was to assess the impact of cognitive function on compliance with treatment. 
In the present study, cognitive impairment was found in 38.8% of patients, whose mean age was 70 
y/o, with cognitively impaired patients 6 years older on average than patients with normal cognitive 
function.  
The prevalence of cognitive impairment observed in our sample is similar to previous studies, which 
have reported rates of cognitive impairment of 17%–75% in patients with HF, dependent on the 
severity of HF, intensity of symptoms, and comorbidities [9, 14, 26–30]. The high rate of cognitive 
impairment among patients with HF, consistently reported across studies, highlights the importance of 
cognitive screening in this high-risk population. 
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A study by Huynh et al. demonstrated that even mild cognitive impairment was negatively associated 
with 30-day readmission or mortality rates, independently of other factors [28]. 
In the present study, cognitively impaired patients had higher NYHA classes and numbers of 
hospitalizations for HF exacerbations than patients with normal cognitive function. Published studies 
often report a correlation between disease severity evidenced by NYHA classes III–IV and functional 
or cognitive deficits [12, 31], and describe a positive impact of HF treatment and of cognitive function 
improvement [32]. 
The connection between poor adherence to therapy and cognitive function is not well documented in 
clinical practice, while the few existing reports bring conflicting findings. In some studies, impaired 
cognitive function in HF patients predicted poorer overall adherence [33] and self-care behaviors [34], 
but other studies did not support these findings [24]. 
In a study by Evangelista et al., elderly people were more compliant with diet and exercise 
recommendations than their younger counterparts. There was no difference in terms of other health-
related behaviors [35]. 
In the present study, statistically significant differences in compliance with treatment were found 
between cognitively impaired patients and those with normal cognitive function. Patients with 
cognitive deficits obtained lower scores in all individual domains of the RHFCS questionnaire, and 
lower total scores. In single-factor correlation analysis and simple regression analysis, statistically 
significant correlations were found between cognitive function scores and all compliance 
questionnaire domains. Multiple-factor and multiple regression analyses showed cognitive function to 
be an independent predictor of compliance, particularly in the daily weighing, exercise, and fluid 
intake restriction domains. After adjusting for other variables, multiple-factor analysis showed that 
better cognitive function is a significant independent determinant of higher total compliance scores.  
Dolansky et al. analyzed the correlation between cognitive impairment and compliance with sodium 
intake restrictions. Their results showed that cognitively impaired patients experienced difficulties in 
correctly collecting urine samples for analyses, but cognitive function was not found to be correlated 
with sodium intake in daily diet [36] 
In a study by Cameron et al., mild cognitive impairment was significantly correlated with 
symptom monitoring capabilities, but not with adherence to sodium intake restrictions [13]. Contrary 
to these findings, Dickson et al. found that cognitive function significantly predicted self-care 
maintenance behaviors, specifically including following sodium intake recommendations [11].  
Reported compliance with sodium-restricted diet varies from 50% [37] to 88% [38, 39], and 
the conflicting findings may result from the variety of questionnaires used for assessing both cognitive 
function and compliance. The present study used a compliance assessment questionnaire, while the 
authors cited mainly used self-care questionnaires [11, 13]. 
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In the present study, regular exercise was complied with by a significantly lower percentage of 
patients in the cognitively impaired group, and was one of the least frequently followed 
recommendations, second to body weight monitoring. Moreover, multiple-factor analyses showed 
cognitive function to be an independent predictor of regular exercise. Published studies emphasize the 
fact that as many as 30% of patients stop exercising immediately after HF diagnosis [38], and 41%–
58% do not comply with daily exercise and rest recommendations [35, 37]. 
Older adults with heart failure are known to have a much lower exercise tolerance, largely due to a 
50%–75% decrease in aerobic capacity in addition to well-known alternations in peripheral 
musculoskeletal performance that contribute to fatigue and greater symptom severity [5]. In the study 
by Evangelista, 51% of patients above 70 y/o reported some degree of difficulty complying with 
exercise recommendations [35]. According to Meirelles, lower rates of hospitalization, improved 
physical function, and enhanced health-related quality of life are found in HF patients who routinely 
exercise [40]. Elderly patients who exercised at least 3 times a week were diagnosed with dementia 
less frequently than those who exercised less often [41].  
In the present study, apart from cognitive function, factors such as age, disease severity, 
number of hospitalizations, education, and being in a relationship were found to have a significant 
impact on compliance with treatment.  
Relationship status (being in a relationship) was a significant independent predictor of better 
compliance. The present findings are consistent with preliminary reports from other authors. In a study 
by Wu et al. [42], social support and financial status were significant predictors of dose count and 
dose-days, but were not correlated with the correct amount of doses taken at the right time. Sayers et 
al. observed a correlation between adherence to treatment and emotional support, but not instrumental 
support [43]. Dunbar et al. [44] confirm better adherence and compliance, fewer rehospitalizations, 
and fewer depressive symptoms for patients supported by their families and friends. Those enjoying 
social support maintained a proper diet, exercised regularly, complied with medication, and were able 
to recognize symptoms of decompensation [45]. Similarly, in a study by Ni [46], living alone and 
lacking knowledge were significantly correlated with poor compliance with daily weighing and fluid 
restriction. 
Associations between education and compliance are seldom discussed in published studies. 
The few papers available report no correlation between education and compliance [35, 42], though 
knowledge has been confirmed to be correlated with better non-pharmaceutical compliance [46].  
Murray et al. [47] noted that the frequency of rehospitalizations among HF patients who did 
not follow their therapeutic regimen was three times higher. In the present study, rehospitalizations for 
exacerbations and disease severity were independent predictors of worse compliance. Mockler et al. 
[48] demonstrated that discontinuation of the prescribed treatment was an independent predictor of 
rehospitalization for HF. Non-adherence to therapy was an independent factor associated with higher 
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mortality rates among the participants of the Candesartan in Heart Failure Assessment of Reduction in 
Mortality and Morbidity (CHARM) trial program [49]. Old age, frailty syndrome and comorbidity 
may contribute to non-adherence among HF patients, consequently leading to more frequent 
rehospitalizations, institutionalization and ultimately, death [50]. 
Published evidence for the relationship between functional status (NYHA class) and 
adherence was rated inconsistent due to conflicting evidence. The study by Wu showed that patients 
with higher NYHA classes had lower adherence in terms of the percentage of days that the correct 
doses were taken. However, this study did not find a significant relationship between NYHA class and 
adherence calculated as the percentage of doses taken or the percentage of doses taken on schedule 
[42]. In a study by Rodgers et al., patients with higher NYHA classes had lower non-adherence levels 
[51], but reports also exist that do not indicate a significant correlation between the two variables [52, 
53]. Jones emphasized that patients adhering to daily weight monitoring are less frequently 
rehospitalized for HF exacerbations, and in the present study, cognitively impaired participants had 
particularly low levels of compliance with the daily weighing recommendation, while their numbers of 
hospitalizations were higher, compared to respondents with normal MMSE scores. Non-adherence can 
be explained by polypharmacy, drug interactions, and adverse effects [20]. 
In summary, poorer cognitive function is associated with lower reported adherence among 
older adults with HF. Such findings may help account for the elevated mortality risk in HF patients 
with cognitive impairment. If replicated, clinician assessment of cognitive function among HF patients 
may provide key insight into patients‘ ability to adhere to treatment recommendations. Prospective 
studies that objectively measure treatment compliance (i.e. electronic monitoring) are much needed to 
clarify the relationship between cognitive function and HF patients‘ actual (as opposed to perceived) 
ability to adhere to treatment regimens [54]. 
Conclusion 
Non-compliance is a major problem in elderly patients with HF cognitively impairment.  
The cognitive function is an independent contributor to total compliance and to compliance with non-
pharmaceutical recommendations (daily weighing, exercise, and fluid intake restrictions) in older 
adults with HF. 
Being in a relationship and education are independent predictors of better compliance, while the 
number of rehospitalizations due to HF exacerbations is an independent predictor of worse compliance 
with treatment.  
Early detection of CI may offer an opportunity for intervention and a key strategy for improving 
clinical outcomes in older adults with HF 
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Implications for practice 
Cognitive impairment is a common comorbidity of HF that may affect patients‘ capabilities for 
adhering to prescribed treatment and lifestyle changes.  
Simple memory screening may help identify patients with HF in need of assistance in accomplishing 
optimal self-care and adherence to pharmaceutical and non-pharmaceutical treatment. Cognitive 
function should also be assessed routinely in patients with heart failure, particularly when first 
diagnosed, when changes in treatment regimen occur, and with worsening disease severity, since these 
events have been shown to precede changes in cognitive function. Incorporating geriatric 
performance-based measures in heart failure management would allow for more treatment strategies 
aimed at improving physical function, cognitive outcomes, and quality of life. The role of family and 
social support in contributing to informed and active participation in the treatment process should also 
be emphasized.  
 
Study limitations 
We are well aware of the potential limitations of this study. The most important limitation is the 
fact that the study sample was recruited from a single center. Another limitation is that no other 
methods of adherence monitoring were used besides the self-assessment questionnaire. Studies using 
self-reported questionnaires may yield different results than those measuring adherence using a 
Medication Event Monitoring System. Another problem of using self-reported measures of sodium 
restriction, fluid restriction, and daily weighing adherence is the possible bias present when patients 
lack knowledge on the optimum amounts of sodium and fluids in their daily diet. 
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